CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
about
CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
description
scientific article published on 27 May 2020
@en
name
CUDC-907, a novel dual PI3K an ...... molecular mechanism of action
@en
type
label
CUDC-907, a novel dual PI3K an ...... molecular mechanism of action
@en
prefLabel
CUDC-907, a novel dual PI3K an ...... molecular mechanism of action
@en
P2093
P356
P1476
CUDC-907, a novel dual PI3K an ...... molecular mechanism of action
@en
P2093
Holly Edwards
Hongyan Xia
Jianlei Zhao
Shanshan Bai
Yanrong Yang
P356
10.1111/JCMM.15281
P577
2020-05-27T00:00:00Z